Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaos Papastavrou

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2024
RNA-catalyzed evolution of catalytic RNANikolaos Papastavrou, David P Horning, Gerald F Joyce
Bioorganic & Medicinal Chemistry|July 30, 2013
1-Hydroxypyrazole as a bioisostere of the acetic acid moiety in a series of aldose reductase inhibitorsNikolaos Papastavrou, Maria Chatzopoulou, Kyriaki Pegklidou, et al.
Expert Opinion on Drug Discovery|October 5, 2013
Development of aldose reductase inhibitors for the treatment of inflammatory disordersMaria Chatzopoulou, Kyriaki Pegklidou, Nikolaos Papastavrou, et al.
Chemical Communications (Cambridge, England)|February 7, 2020
Vitamin-guanosine monophosphate conjugates for in vitro transcription primingNikolaos Papastavrou, Omprakash Bande, Philippe Marlière, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 16, 2015
N-substituted pyrrole-based scaffolds as potential anticancer and antiviral lead structuresKyriaki Pegklidou, Nikolaos Papastavrou, Petros Gkizis, et al.
European Journal of Medicinal Chemistry|March 6, 2017
Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: The case of trifluoroacetylationNikolaos Papastavrou, Maria Chatzopoulou, Jana Ballekova, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|March 4, 2024
RNA-catalyzed evolution of catalytic RNANikolaos Papastavrou, David P Horning, Gerald F Joyce
Bioorganic & Medicinal Chemistry|July 30, 2013
1-Hydroxypyrazole as a bioisostere of the acetic acid moiety in a series of aldose reductase inhibitorsNikolaos Papastavrou, Maria Chatzopoulou, Kyriaki Pegklidou, et al.
Expert Opinion on Drug Discovery|October 5, 2013
Development of aldose reductase inhibitors for the treatment of inflammatory disordersMaria Chatzopoulou, Kyriaki Pegklidou, Nikolaos Papastavrou, et al.
Chemical Communications (Cambridge, England)|February 7, 2020
Vitamin-guanosine monophosphate conjugates for in vitro transcription primingNikolaos Papastavrou, Omprakash Bande, Philippe Marlière, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|March 16, 2015
N-substituted pyrrole-based scaffolds as potential anticancer and antiviral lead structuresKyriaki Pegklidou, Nikolaos Papastavrou, Petros Gkizis, et al.
European Journal of Medicinal Chemistry|March 6, 2017
Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: The case of trifluoroacetylationNikolaos Papastavrou, Maria Chatzopoulou, Jana Ballekova, et al.
Pageof 1